Radiofrequency ablation for thyroid nodules in Ecuador: a cross-sectional study.

OBJECTIVES: To describe the demographic characteristics and clinical outcomes following the first cohort of patients with Bening Thyroid Nodule (BTN) and (Papillary Thyroid Microcarcinoma) (PTMC) treated with Radiofrequency Ablation (RFA)in Ecuador. METHODS: Single-center, cross-sectional study. We included adults undergoing RFA for BTN and PTMC between July 2019 and May 2022. Descriptive statistics and the Wilcoxon signed-rank test were used to compare some pre- and post-intervention outcomes. RESULTS: We included 44 patients with 36 BTNs and eight PTMCs. The median age was 45.80 years (IQR 16-79 years), and most patients had normal thyroid function (72.72%). The median follow-up time was 7.80 months (IQR1.0-34.0). Nodules were primarily solid (43.21%) or predominantly solid (56.81%). The pre-RFA median volume in the benign lesions group was 10.30 ml (IQR 1.86-18.97). After ablation, the 1-month, 3-month, 6-month, and 12-month median volumes were 6.90 (IQR 0.48-10.15; p < 0.01) mL, 5.72 (IQR 0.77-7.25; p = 0.045); 0.98 (IQR 0.25-3.64; p < 0.01), and 0.11 (IQR 0.07-11.26; p = 0.026), respectively. The volume rate reduction was 47.20%, 72.20%, 74.00%, and 96.20% at 1, 3, 6, and 12-month follow-ups, respectively. The pre-RFA median volume in the PTMC group was 0.25 ml (IQR 0.19-0.48). After ablation, the 1-month, 3-month, and 6-month mean volumes were 0.19 (range 0.12-0.31; p = 0.120) mL, 0.10 (IQR 0.05-0.15; p = 0.13), and 0.01 (IQR 0.005-0.04; p = 0.364), respectively. CONCLUSIONS: In this first report from Ecuador, we found that RFA may be a feasible alternative for treating benign and malignant thyroid nodules in the short term. Long-term data are needed to evaluate oncologic outcomes in PTMC patients.

The iceberg technique: an innovative approach for radiofrequency ablation of diving thyroid nodules.

Diving thyroid nodules are a limitation of radiofrequency ablation because the mediastinal component cannot be adequately identified by ultrasound (US). We aim to describe a new technique, the iceberg technique, to overcome this issue and explain our three-year experience of using this novel method. The iceberg technique consists of a two-stage treatment. First, the ablation of the cervical portion of the nodules (easily visualized during the initial US exam) using trans-isthmic access is performed using the moving-shot technique. After three to six months, there is a volumetric reduction of the treated portion, leading to retraction of the thyroid parenchyma. This brings the mediastinal component to the cervical region, thereby enabling a perfect visualization by US. Then, the second stage of treatment is carried out with complete nodule ablation, and the region that was treated first is looked at a second time. From April 2018 to April 2021, nine patients with nine benign nodules were submitted for the iceberg technique. No complications occurred during the entire follow-up period. The patients displayed normal hormonal levels after the procedures, and there was a significant volume reduction of the nodules until three months post-ablation. The iceberg technique is an effective and safe option for the radiofrequency treatment of diving goiters.

Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association.

BACKGROUND: The use of ultrasound-guided ablation procedures to treat both benign and malignant thyroid conditions is gaining increasing interest. This document has been developed as an international interdisciplinary evidence-based statement with a primary focus on radiofrequency ablation and is intended to serve as a manual for best practice application of ablation technologies. METHODS: A comprehensive literature review was conducted to guide statement development and generation of best practice recommendations. Modified Delphi method was applied to assess whether statements met consensus among the entire author panel. RESULTS: A review of the current state of ultrasound-guided ablation procedures for the treatment of benign and malignant thyroid conditions is presented. Eighteen best practice recommendations in topic areas of preprocedural evaluation, technique, postprocedural management, efficacy, potential complications, and implementation are provided. CONCLUSIONS: As ultrasound-guided ablation procedures are increasingly utilized in benign and malignant thyroid disease, evidence-based and thoughtful application of best practices is warranted.

Hydrodissection and programmed stop sedation in 100 % of benign thyroid nodules treated with radiofrequency ablation.

PURPOSE: To describe our group experience in treatment of benign symptomatic thyroid nodules using radiofrequency ablation technique always associated to routine pre-procedure hydrodissection and under sedation with programmed stop. METHODS: Dual-center, retrospective study conducted between April 2018 and January 2020. A total of 52 symptomatic benign thyroid nodules were treated in 34 patients with ultrasound-guided percutaneous radiofrequency ablation. The technique of choice was moving-shot technique and 100 % patients underwent pre-procedural hydrodissection with 5% glucose solution, plus conscious sedation with programmed stop during procedure. RESULTS: Most nodules were solid or almost completely solid (n = 45, 88.3 % of nodules), followed by cystic composition (n = 4, 7.8 %) and mixed (n = 2, 3.9 %). As for location, most were on the right lobe (n = 29, 56.9 %), followed by the left lobe (n = 17, 33.3 %) and isthmus (n = 5, 9.8 %). The average volume of nodules before ablation was 18.2 ±â€¯20.5 mL. Volumetric reduction rates at one, three, six and twelve months after ablation were 46.6 %, 64.5 %, 76.1 % and 88.8 %, respectively. No complications strictly related to procedure were reported. No more than 5 min were added to total time of ablative treatment considering routine hydrodissection and stop programmed sedation. CONCLUSIONS: Minimally invasive therapies applied to thyroid allow the preservation of healthy thyroid parenchyma and provide a very effective volumetric reduction of symptomatic benign thyroid nodules. Hydrodissection with 5 % glucose solution, conscious sedation and patient stimulation with programmed stop during procedure may provide greater safety to procedure, and, in our experience, could be done routinely in all patients.

Radiofrequency for benign and malign thyroid lesions.

BACKGROUND: Thermal ablation of thyroid nodules is new modality for the management of the benign and malign lesions. This minimally invasive treatment is performed as an outpatient, local anesthetic, single professional procedure that can treat neoplastic lesions without removing normal thyroid tissue and thus avoiding hypothyroidism. METHOD: A comprehensive review of the most relevant literature regarding the thermal ablation of benign and malign nodules was performed in order to currently define its role on the management of the nodular thyroid disease. The data was divided into benign and malign literature. RESULTS: The benign nodules can be effectively treated by radiofrequency ablation (RFA) but some limitation exists regarding the nodule's size but not nodules characteristics. The RFA of primary malign tumors of the thyroid recently demonstrated positive and safe long-term follow-up and encouraged additional investigation and possibly a definitive role in the management of these low risk nodules. CONCLUSION: RFA is a safe, cost-effective minimally invasive procedure that avoids thyroid tissue removal while destroying neoplastic one thus, preventing hypothyroidism.

International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic data.

The purpose of this publication was to inform surgeons as to the modern state-of-the-art evidence-based guidelines for management of the recurrent laryngeal nerve invaded by malignancy through blending the domains of 1) surgical intraoperative information, 2) preoperative glottic function, and 3) intraoperative real-time electrophysiologic information. These guidelines generated by the International Neural Monitoring Study Group (INMSG) are envisioned to assist the clinical decision-making process involved in recurrent laryngeal nerve management during thyroid surgery by incorporating the important information domains of not only gross surgical findings but also intraoperative recurrent laryngeal nerve functional status and preoperative laryngoscopy findings. These guidelines are presented mainly through algorithmic workflow diagrams for convenience and the ease of application. These guidelines are published in conjunction with the INMSG Guidelines Part I: Staging Bilateral Thyroid Surgery With Monitoring Loss of Signal. Level of Evidence: 5 Laryngoscope, 128:S18-S27, 2018.

International neural monitoring study group guideline 2018 part I: Staging bilateral thyroid surgery with monitoring loss of signal.

This publication offers modern, state-of-the-art International Neural Monitoring Study Group (INMSG) guidelines based on a detailed review of the recent monitoring literature. The guidelines outline evidence-based definitions of adverse electrophysiologic events, especially loss of signal, and their incorporation in surgical strategy. These recommendations are designed to reduce technique variations, enhance the quality of neural monitoring, and assist surgeons in the clinical decision-making process involved in surgical management of recurrent laryngeal nerve. The guidelines are published in conjunction with the INMSG Guidelines Part II, Optimal Recurrent Laryngeal Nerve Management for Invasive Thyroid Cancer-Incorporation of Surgical, Laryngeal, and Neural Electrophysiologic Data. Laryngoscope, 128:S1-S17, 2018.

Substernal goiter and laryngopharyngeal reflux

ABSTRACT Objective This study aims to compare the prevalence of laryngopharyngeal reflux signs between two groups of patients undergoing thyroidectomy for voluminous goiter: substernal goiters and voluminous cervical goiter without thoracic extension. Subjects and methods A retrospective case-control study was performed with data retrieved of the charts of the patients submitted to thyroidectomies occurred at a tertiary care center (Head and Neck Surgery Department, University of São Paulo Medical School) between 2010 and 2014. The selected thyroidectomies were allocated in two groups for study: patients with substernal goiters and patients with voluminous cervical goiter without thoracic extension. Cervical goiters were selected by ultrasonography mensuration. Clinical criterion was used to define substernal goiter. Results The average thyroid volume in patients with substernal goiter was significantly greater than the average volume in patients with only cervical goiter (p < 0.001). The prevalence of signs of reflux laryngitis at laryngoscopy was significantly greater in substernal goiter patients (p = 0.036). Moreover, substernal goiter was considered as the unique independent variable for high reflux laryngitis signs at laryngoscopy (OR = 2.75; CI95%: 1.05-7.20; p = 0.039) when compared to only cervical goiter patients. Conclusion This study shows a significant association between substernal goiters and signs of laryngopharyngeal reflux at preoperative laryngoscopy. Therefore, when compared with voluminous cervical goiters, the substernal goiters increase the chance of reflux laryngitis signs in patients.

Substernal goiter and laryngopharyngeal reflux.

OBJECTIVE: This study aims to compare the prevalence of laryngopharyngeal reflux signs between two groups of patients undergoing thyroidectomy for voluminous goiter: substernal goiters and voluminous cervical goiter without thoracic extension. SUBJECTS AND METHODS: A retrospective case-control study was performed with data retrieved of the charts of the patients submitted to thyroidectomies occurred at a tertiary care center (Head and Neck Surgery Department, University of São Paulo Medical School) between 2010 and 2014. The selected thyroidectomies were allocated in two groups for study: patients with substernal goiters and patients with voluminous cervical goiter without thoracic extension. Cervical goiters were selected by ultrasonography mensuration. Clinical criterion was used to define substernal goiter. RESULTS: The average thyroid volume in patients with substernal goiter was significantly greater than the average volume in patients with only cervical goiter (p < 0.001). The prevalence of signs of reflux laryngitis at laryngoscopy was significantly greater in substernal goiter patients (p = 0.036). Moreover, substernal goiter was considered as the unique independent variable for high reflux laryngitis signs at laryngoscopy (OR = 2.75; CI95%: 1.05-7.20; p = 0.039) when compared to only cervical goiter patients. CONCLUSION: This study shows a significant association between substernal goiters and signs of laryngopharyngeal reflux at preoperative laryngoscopy. Therefore, when compared with voluminous cervical goiters, the substernal goiters increase the chance of reflux laryngitis signs in patients.

The learning progression of diagnostic sialendoscopy / Progressão do aprendizado da sialoendoscopia diagnóstica

ABSTRACT INTRODUCTION: Sialendoscopy is becoming the gold standard procedure for diagnosis and treatment of Salivary Gland Inflammatory Diseases. OBJECTIVE: To evaluate the learning progression of a single surgeon to implement and perform diagnostic sialendoscopy: to estimate how many procedures were necessary to achieve better results; if it was higher rate of complications in the beginning. METHODS: Retrospective analysis involving 113 consecutive sialendoscopies performed from 2010 to 2013. According to a descriptive analysis of the factors related to surgeon's experience, the casuistic was divided into two groups: group (A) comprising the first 50 exams, and group (B) the last 63. Groups were then compared concerning demographic and peri-operative aspects. RESULTS: In Group A, failure to catheterize papilla were 22% versus 3% in B (p = 0.001). Failure to complete examination was 30% in group A versus 6% in B (p = 0.001), and necessity to repeat exams was 22% in group A versus 10% in B (p = 0.058). The complication rates were 18% in group A, and 10% in B (p = 0.149). Operative time was slightly shorter in group B (56 versus 41 min, p = 0.045). CONCLUSION: We found better outcomes after the first 50 diagnostic sialendoscopies. Complication rates were statistically the same between early and late groups of experience with sialendoscopy.

RESUMO INTRODUÇÃO: A sialoendoscopia vem se tornando o procedimento de referência para o diagnóstico e o tratamento das doenças inflamatórias da glândula salivar. OBJETIVO: Avaliar a progressão de aprendizado de um mesmo cirurgião para implementação e realização da sialoendoscopia diagnóstica: verificar quantos procedimentos foram necessários para a obtenção de resultados melhores e se houve ocorrência de maior taxa de complicações no início do aprendizado. MÉTODO: Análise retrospectiva envolvendo 113 sialoendoscopias consecutivas realizadas de 2010 a 2013. De acordo com uma análise descritiva dos fatores relacionados à experiência do cirurgião, a casuística foi dividida em dois grupos: grupo (A), compreendendo os primeiros 50 exames; e grupo (B), os últimos 63. Em seguida, os grupos foram comparados, levando em consideração os aspectos demográficos e perioperatórios. RESULTADOS: No grupo A, a não realização do cateterismo papilar foi de 22% vs. 3% em B (p = 0,001). A não realização de um exame completo foi de 30% no grupo A vs. 6% em B (p = 0,001), e a necessidade de repetir o exame foi de 22% no grupo A vs. 10% em B (p = 0,058). Os percentuais de complicações foram 18% no grupo A e 10% em B (p = 0,149). O tempo operatório foi ligeiramente menor no grupo B (56 vs. 41 minutos, p = 0,045). CONCLUSÃO: Verificamos melhores desfechos após as 50 primeiras sialoendoscopias diagnósticas. Os percentuais de complicações foram estatisticamente semelhantes entre os grupos inicial e avançado de experiência com a sialoendoscopia.

The learning progression of diagnostic sialendoscopy.

INTRODUCTION: Sialendoscopy is becoming the gold standard procedure for diagnosis and treatment of Salivary Gland Inflammatory Diseases. OBJECTIVE: To evaluate the learning progression of a single surgeon to implement and perform diagnostic sialendoscopy: to estimate how many procedures were necessary to achieve better results; if it was higher rate of complications in the beginning. METHODS: Retrospective analysis involving 113 consecutive sialendoscopies performed from 2010 to 2013. According to a descriptive analysis of the factors related to surgeon's experience, the casuistic was divided into two groups: group (A) comprising the first 50 exams, and group (B) the last 63. Groups were then compared concerning demographic and peri-operative aspects. RESULTS: In Group A, failure to catheterize papilla were 22% versus 3% in B (p=0.001). Failure to complete examination was 30% in group A versus 6% in B (p=0.001), and necessity to repeat exams was 22% in group A versus 10% in B (p=0.058). The complication rates were 18% in group A, and 10% in B (p=0.149). Operative time was slightly shorter in group B (56 versus 41 min, p=0.045). CONCLUSION: We found better outcomes after the first 50 diagnostic sialendoscopies. Complication rates were statistically the same between early and late groups of experience with sialendoscopy.

Continuous intraoperative neuromonitoring in thyroid surgery: Safety analysis of 400 consecutive electrode probe placements with standardized procedures.

BACKGROUND: Continuous intraoperative neuromonitoring (C-IONM) is a new technology and it is appropriate to analyze its safety. METHODS: C-IONM was performed according to a standardized technique to control any adverse events and electrode positioning issues. RESULTS: Four hundred vagal nerve dissections were analyzed considering vagal nerve diameter, mean time effort for C-IONM probe positioning, and electrode dislocation rate. A significant superior dislocation rate in case of: (a) when a 3 mm automatic periodic stimulating (APS) electrode size was used in a vagal nerve diameter <2 mm; (b) anterior access; and (c) vagal nerve A subtype in relation (p < .05). No related additional local or systemic morbidity was registered in this series. There was a statistically significant positive relationship between increased diameter of vagal nerve and increased electromyography (EMG) amplitude (p = .03). There was also a significant increase of amplitude between initial and final vagal nerve stimulation in uneventful cases (p = .02). CONCLUSION: We analyzed the technical issues to achieve improved vagal nerve critical view of safety dissection, stimulation, and C-IONM probe placement. © 2015 Wiley Periodicals, Inc. Head Neck 38: E1568-E1574, 2016.

A associação dos níveis séricos de TSH com o risco de câncer bem diferenciado de tireoide e sua relação com a agressividade da doença / The association of serum TSH with the risk of well-differentiated thyroid cancer and its relation with disease aggressiveness

Introdução: O câncer de tireoide é a neoplasia endócrina de maior prevalência, e sua incidência vem aumentando nos últimos anos. Estudos anteriores sugeriram que o nível sérico de Hormônio Estimulante de Tireoide (TSH) é um fator de risco independente para o desenvolvimento de cânceres bem diferenciados de tireoide. Além disso, alguns desses estudos demonstraram que altos níveis de TSH estão relacionados a estágios mais avançados de doença. Objetivos: O objetivo do presente estudo é averiguar se os níveis de TSH, mesmo dentro da faixa da normalidade, se correlacionam com maior incidência e maior agressividade dos carcinomas bem diferenciados de tireoide. Métodos: Analisamos os dados de 1180 pacientes submetidos a tireoidectomia total pela equipe da Disciplina de Cirurgia de Cabeça e Pescoço do HC-FMUSP, sendo 57,9% devido a doenças benignas e 42,1% a neoplasias malignas de tireoide. Para cada paciente, adotamos os valores absolutos de TSH referentes à última coleta antes da cirurgia, e os resultados dos exames anatomopatológicos (AP). Resultados: A comparação dos níveis de TSH estratificado nos pacientes com doenças benignas e com neoplasias malignas demonstrou uma associação estatisticamente significativa (p < 0,0001), nos permitindo inferir que pacientes com valor de TSH sérico maior de 1,16 µIU/mL tem maior risco de serem portadores de câncer bem diferenciado de tireoide do que aqueles que tem níveis de TSH menor ou igual a este valor. Porém, quando comparamos o estadio final dos CBT com os níveis de THS estratificado não houve associação significativa (p = 0,585), e assim pelos nossos resultados não podemos afirmar que valores de TSH maiores de 1,16 µIU/mL estão associados a maior gravidade no câncer de tireoide.

Introduction: The thyroid cancer is the most common endocrine malignancy, and its incidence has increased in recent years. Previous studies have suggested that serum Thyroid Stimulating Hormone (TSH) is an independent risk factor for the development of well differentiated thyroid cancer. Furthermore, some of these studies showed that high TSH levels are related to more advanced stages of disease. Objective: The aim of the present study is to investigate if serum THS levels, even whitin the normal range, are related with higher incidence and increased aggressiveness of well-differentiated thyroid carcinomas. Methods: We analyzed data of 1180 patients who underwent total thyroidectomy by the Discipline of Head and Neck Surgery from Hospital das Clinicas of University of São Paulo (HC-FMUSP). 57.9% was due to benign diseases and 42,1% was due to malignant neoplasms. For each patient, we adopted the value of serum TSH reference to the last collection before surgery, and the results of the pathologic exams. Results: The comparison of the stratified TSH levels in the patients with benign diseases and malignant neoplasms showed a statistically significant association (p < 0,0001), allowing us to infer that patients with TSH levels higher than 1,16 µIU/mL have higher risk of being carriers of well differentiated thyroid cancer than those who TSH levels less than or equal to this value. But when we compared the final stage of CBT with the stratified TSH levels, there was no significant association (p = 0,585), and so by our results we cannot say that THS levels higher then 1,16 µIU/mL are associated with more advanced stage of disease.

External branch of the superior laryngeal nerve monitoring during thyroid and parathyroid surgery: International Neural Monitoring Study Group standards guideline statement.

UNLABELLED: Intraoperative neural monitoring (IONM) during thyroid surgery has gained widespread acceptance as an adjunct to the gold standard of visual identification of the recurrent laryngeal nerve (RLN). Contrary to routine dissection of the RLN, most surgeons tend to avoid rather than routinely expose and identify the external branch of the superior laryngeal nerve (EBSLN) during thyroidectomy or parathyroidectomy. IONM has the potential to be utilized for identification of the EBSLN and functional assessment of its integrity; therefore, IONM might contribute to voice preservation following thyroidectomy or parathyroidectomy. We reviewed the literature and the cumulative experience of the multidisciplinary International Neural Monitoring Study Group (INMSG) with IONM of the EBSLN. A systematic search of the MEDLINE database (from 1950 to the present) with predefined search terms (EBSLN, superior laryngeal nerve, stimulation, neuromonitoring, identification) was undertaken and supplemented by personal communication between members of the INMSG to identify relevant publications in the field. The hypothesis explored in this review is that the use of a standardized approach to the functional preservation of the EBSLN can be facilitated by application of IONM resulting in improved preservation of voice following thyroidectomy or parathyroidectomy. These guidelines are intended to improve the practice of neural monitoring of the EBSLN during thyroidectomy or parathyroidectomy and to optimize clinical utility of this technique based on available evidence and consensus of experts. LEVEL OF EVIDENCE: 5

Concomitância de carcinoma papilífero e tireoidite de hashimoto em pacientes submetidos a tireoidectomia total: Análise da casuística e revisão da literatura / Coexistence of papillary thyroid carcinoma and hashimoto?s thyroiditis in patients submitted to total thyroidectomy: Retrospective case series and literature review

Introdução: A Tireoidite de Hashimoto (TH) é a causa mais comumde hipotireoidismo e é caracterizada pela insuficiência tireoidianaprogressiva de causa autoimune. O carcinoma papilífero detireoide (CPT) é a forma mais prevalente de câncer da tireoidecorrespondendo a 70 - 80% de todos os casos. Estudos atuaisdemonstram coexistência entre 11 e 38% entre TH e CPT e queas doenças compartilham muitas características morfológicase moleculares, mas a importância clínica desta correlaçãopermanece indefinida. Objetivo: Avaliar a concomitância deTH em doenças benignas e malignas em tireoidectomias totais.Método: No presente estudo comparamos a concomitância deTH em doenças benignas e malignas no anatomopatológico de100 tireoidectomias consecutivas realizadas entre os meses dejunho a setembro de 2009, por um mesmo cirurgião. Resultados:A presença de TH em casos malignos foi de 47,7% e em doençasbenignas de 26,7% (p<0,05). Conclusão: A coexistência de THe CPT é maior do que em doenças benignas, o que dá suporte àteoria de que a TH seja um fator de risco para o desenvolvimentodo CPT. Nódulos em pacientes com TH devem ser avaliadosprecocemente e seguidos com cautela.

Mapeamento do linfonodo sentinela para carcinoma epidermoide de cavidade oral T1 e T2: a eficácia é mesma do melanoma cutâneo / Sentinel lymph node mapping for T1/T2 oral squamous cell carcinoma: does it have the same efficacy as for cutaneous melanoma

Introdução: O mapeamento do linfonodo sentinela (MLNS) é umatécnica valor no estadiamento linfático dos tumores sólidos e setornou padrão no estadiamento do melanoma cutâneo não sendoainda considerado padrão para estadiamento de carcinomas decavidade oral. Objetivo: Estudar o MLNS como procedimentodiagnóstico e de estadiamento e comparar sua acurácia à do MLNSpara o melanoma cutâneo de Cabeça e Pescoço. Método: Foramanalisados 104 MLNS, 32 com carcinoma de cavidade oral T1 ouT2N0 (grupo A) e 72 melanomas cutâneos estadiados T1b ou maise N0 (grupo B). Foram analisados sensibilidade, especificidadevalor preditivo positivo (VPP), valor preditivo negativo (VPN) eacurácia de ambos grupos. Resultados: A idade média do grupoA foi de 62 anos com 25 homens (77%). Para o grupo B, a mesmafoi de 58 anos com 37 homens (51%). Pelo menos um LinfonodoSentinela foi localizado em 31/32 pacientes no grupo A (96,8%)e 70/72 no Grupo B (97,2%). Tivemos 1 resultado falso negativono grupo A com 83% de sensibilidade, 100% de especificidadeVPP de 100% e VPN de 96,1%. A acurácia total foi de 96,7%. Nogrupo B houve 2 falso negativos, 88% de sensibilidade, 100%de especificidade, VPP de 100%, VPN de 96,4% com acuráciade 97,1% nesse grupo. Conclusão: A acurácia do MLNS paraestadiamento de Carcinoma de cavidade oral T1:T2 é comparávelao método de MLNS para o melanoma cutâneo em Cabeça ePescoço. Descritores: carcinoma epidermoide, cavidade oral,Linfonodo Sentinela, Estadiamento Cervical, melanoma cutâneo.